| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $113.7M | -12.8% |
| Cost of Revenue | $75.1M | -25.9% |
| Gross Profit | $38.6M | +33.0% |
| R&D Expense | $38.4M | -33.0% |
| SG&A Expense | $43.5M | -3.8% |
| Operating Income | -$113.4M | +33.2% |
| Interest Expense | $23.9M | +88.3% |
| Pre-tax Income | -$127.5M | +26.0% |
| Income Tax | $491K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $124.0M | +81.0% |
| Short-term Investments | $34.7M | -74.3% |
| Accounts Receivable | $35.6M | +8.0% |
| Inventory | $59.4M | +20.7% |
| Current Assets | $258.2M | -11.3% |
| Total Assets | $275.8M | -12.1% |
| Current Liabilities | $45.4M | -18.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$116.3M | +11.5% |
| Capital Expenditures | $912K | -73.5% |
| Investing Cash Flow | $103.9M | +25.2% |
| Financing Cash Flow | $67.9M | +55.5% |
| Free Cash Flow | -$117.2M | +13.1% |
| -6.1% |
| Net Income | -$128.0M | +25.9% |
| EPS (Basic) | -$2.46 | +29.3% |
| EPS (Diluted) | -$2.46 | +29.3% |
| Long-term Debt |
| $197.4M |
| +51.7% |
| Total Liabilities | $249.0M | +30.4% |
| Stockholders' Equity | $26.8M | -78.2% |